Slingshot members are tracking this event:
CymaBay (CBAY) to Present Two Phase 2 Studies of Arhalofenate for Gout Patients at the American College of Rheumatology Annual Meeting
Slingshot Insights Explained
Nov 07, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Gout, Phase 2, Arhalofenate